VTRS (Viatris Inc.) חוב לטווח קצר להון

Viatris Inc. (VTRS) generates revenue through the wholesale supply of biosimilars and well-known generics to global clinics. The short-term debt-to-equity ratio visualizes market tension, with this metric currently standing at 0.13. The holding's survival is ensured by the massive scale of its logistics amidst severe pricing pressure. The company is currently transforming its portfolio toward ophthalmology and the reduction of its debt load.

This ratio determines the level of credit risk by assessing the capital structure's dependence on external borrowings. The metric is calculated as the ratio of liabilities with a maturity of more than one year to the company's equity. Analyzing the short leverage indicator allows for the tracking of debt load dynamics in real time. For Viatris Inc. (VTRS), as a key provider of affordable generics, the debt balance is critical for maintaining global production.